Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Disc Medicine has raised $225.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Disc Medicine's investors include Janus Henderson Investors, Novo Holdings, TCG Crossover, Wellington Management, Adage Capital Management.
Disc Medicine is headquartered in Watertown, United States.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Disc Medicine is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Disc Medicine — Funding & Investors." VCBacked, October 21, 2025, https://www.vcbacked.co/company/disc-medicine. Accessed August 14, 2026.
VCBacked. (2025). Disc Medicine — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/disc-medicine
{{cite web |title=Disc Medicine — Funding & Investors |url=https://www.vcbacked.co/company/disc-medicine |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated